# Strategies for Management of Corneal Neovascularisation

> **NCT02594423** · PHASE4 · UNKNOWN · sponsor: **University of Nottingham** · enrollment: 40 (estimated)

## Conditions studied

- Corneal Neovascularisation

## Interventions

- **DEVICE:** Fine Needle Diathermy
- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT02594423
- **Lead sponsor:** University of Nottingham
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12
- **Primary completion:** 2017-08
- **Final completion:** 2018-08
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2015-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02594423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02594423, "Strategies for Management of Corneal Neovascularisation". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02594423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*